Pharma Journalist - Page 671 of 834 -

Axcynsis Receives FDA Clearance for IND of AT03-65, CLDN6-Targeting ADC

FDA Approves Lilly’s Omvoh for Crohn’s Disease, Expanding IBD Treatment Options

AbbVie and Simcere Zaiming Partner to Develop Trispecific Antibody for Multiple Myeloma

Mallinckrodt Completes Sale Of RECOTHROM And PREVELEAK To Baxter

Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada

Nexcelom Bioscience announces strategic growth investment from Ampersand Capital Partners

Mylan Adds to Growing Oncology Portfolio with Launch of Generic Mutamycin Injection

MHRA Grants UK Patients Early Access to Akcea Therapeutics’ Volanesorsen for FCS

Kalytera Initiates Program to Develop a Novel Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain

Piedmont Healthcare Expands Use of Glytec’s Software for Insulin Therapy Management

Elligo Health Research Raises $16M to Improve Access to Clinical Trials

Bicycle Therapeutics Promotes Michael Skynner to Chief Operating Officer

Intezyne Partners with Exosome Diagnostics on IT-139 Companion Diagnostic